Demand for new antibiotics surges as drug-resistant and emerging infections become an increasingly severe global health threat. Researchers are racing to reexamine certain microbes that serve as one of our most successful sources of therapeutics: the actinomycetes. Scientists at Washington University in St. Louis and the University of Hawaii discovered a potential candidate for drug development from...